文献速递肝病

肝硬化患者炎症的临床意义

Clinical Implications of Inflammation in Patients With Cirrhosis.
PubMed 文献 · Am J Gastroenterol · 2024-08-27

本文综述肝硬化相关免疫功能障碍,涵盖从代偿期低度炎症到慢加急性肝衰竭重度炎症伴免疫麻痹的疾病谱。系统炎症是急性失代偿和肝硬化由代偿向失代偿进展的关键驱动因素,可促发器官功能障碍、肝性脑病和肝肾综合征-急性肾损伤,并可能参与肝细胞癌和精神疾病的发病机制。炎症最严重的患者预后最差。

要点

  • 肝硬化相关免疫功能障碍表现为系统性炎症与免疫麻痹并存,贯穿全疾病谱。
  • 系统性炎症是急性失代偿及代偿进展为失代偿的关键驱动因素。
  • 炎症最严重的患者预后最差。

核心结论

  • 系统性炎症在肝硬化病程中起关键作用,是急性失代偿及代偿进展为失代偿的关键驱动因素。
  • 重度系统性炎症是器官功能障碍与衰竭及慢加急性肝衰竭发生的基础。
  • 系统性炎症最严重的患者预后最差。

研究设计与样本

  • 本文为综述,检索范围原文未报告。

主要发现

  • 系统性炎症通过一氧化氮介导的内脏血管扩张增加、免疫病理和代谢重分配等机制产生负面临床效应。
  • 系统性炎症促进肝性脑病和肝肾综合征-急性肾损伤的发生发展。
  • 系统性炎症可能参与肝细胞癌和精神疾病等其他并发症的发病机制。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cirrhosis-associated immune dysfunction refers to the concurrent systemic inflammation and immunoparesis evident across the disease spectrum of chronic liver disease, ranging from the low-grade inflammatory plasma milieu that accompanies compensated disease to the intense high-grade inflammatory state with coexistent severe immune paralysis that defines acute decompensation and acute-on-chronic liver failure. Systemic inflammation plays a crucial role in the disease course of cirrhosis and is a key driver for acute decompensation and the progression from compensated to decompensated cirrhosis. Severe systemic inflammation is fundamental to the development of organ dysfunction and failure and, in its most extreme form, acute-on-chronic liver failure. Systemic inflammation propagates the development of hepatic encephalopathy and hepatorenal syndrome-acute kidney injury. It may also be involved in the pathogenesis of further complications such as hepatocellular carcinoma and mental illness. Those patients with the most profound systemic inflammation have the worst prognosis. Systemic inflammation exerts its negative clinical effects through a number of mechanisms including nitric oxide-mediated increased splanchnic vasodilation, immunopathology, and metabolic reallocation.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Kronsten VT, Shawcross DL. Clinical Implications of Inflammation in Patients With Cirrhosis. Am J Gastroenterol. 2024. PMID: 39194320. doi:10.14309/ajg.0000000000003056

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。